Paul Hasty
7Patents
3h-index
7Co-inventors
50Inventor score
Filing activity: Feb 22, 1994 → Dec 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5614396A | Methods for the genetic modification of endogenous genes in animal cells by homologous recombination | Human Necessities | 171 | Expired |
| US6037125A | Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells | Human Necessities | 7 | Expired |
| US6057104A | Disruption of the mammalian Rad51 protein and disruption of proteins that associate with mammalian Rad51 for hindering cell proliferation | Human Necessities | 7 | Expired |
| US11191750B2 | Use of mTOR inhibitors for treatment of familial adenomatous polyposis | Human Necessities | 2 | Active |
| US5955644A | Ku deficient cells and non-human transgenic animals | Chemistry; Metallurgy | 1 | Expired |
| US6057489A | MmRad51-deficient cells and transgenic mice | Chemistry; Metallurgy | 0 | Expired |
| US12383538B2 | Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.